Signal transduction pathways involved in BCR-ABL transformation

Bailliere's Clinical Haematology

Volumn 10, Issue 2, 1997, Pages 223-231

  Sawyers, C L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

MAP kinase; Myc; P13 K; Philadelphia chromosome; Ras; STAT; Tyrosine kinase

Indexed keywords

BCR ABL PROTEIN; HYBRID PROTEIN; PROLINE; PROTEIN TYROSINE KINASE; TYROSINE;

ACUTE LYMPHOCYTIC LEUKEMIA; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; GENETIC TRANSFORMATION; HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030766684     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(97)80004-2     Document Type: Article

References (61)

1. Afar DEH Goga A McLaughlin J Differential complementation of Bcr-Abl point mutants with c-Myc Science 264 1994 424 426
2. Anderson SM Mladenovic J The BCR-ABL oncogene requires both kinase activity and srchomology 2 domain to induce cytokine secretion Blood 87 1996 238 244
3. Baines P Truran L Bailey-Wood R Haemopoietic colony-forming cells from peripheral blood stem cell harvests: cytokine requirements and lineage potential British Journal of Haematology 88 1994 472 480
4. Cano E Mahadevan LC Parallel signal processing among mammalian MAPKs Trends in Biochemical Science 20 1995 117 122
5. Carlesso N Frank DA Griffin JD Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl Journal of Experimental Medicine 183 1996 811 820
6. Carpenter CL Cantley LC Phosphoinositide kinases Current Opinion in Cell Biology 8 1996 153 158
7. dok: a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells Cell 88 1997 197 204
8. Cleveland JL Dean M Rosenberg N Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl Molecular and Cell Biology 9 1989 5685 5695
9. Cortez D Kadlec L Pendergast AM Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis Molecular and Cell Biology 15 1995 5531 5541
10. Cortez D Stoica G Pierce JH Pendergast AM The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway Oncogene 13 1996 2589 2594
11. Danial NN Pernis A Rothman PB Jak-STAT signaling induced by the v-abl oncogene Science 269 1995 1875 1877
12. Davis RJ MAPKs: new JNK expands the group Trends in Biochemical Science 19 1994 470 473
13. Dickens M, Rogers J, Cavanagh J et al (in press) A cytoplasmic inhibitor of the JNK signal transduction pathway. Science .
14. Gishizky ML Cortez D Pendergast AM Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation Proceedings of the National Academy of Sciences of the USA 92 1995 10 889 10 893
15. Goga A McLaughlin J Afar DE Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene Cell 82 1995 981 988
16. Golub TR Goga A Barker GF Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukaemia Molecular and Cell Biology 16 1996 4107 4116
17. + ALL involve GTPase-activating protein, phospholipase C-gamma 1, and phosphatidylinositol 3′-kinase Leukemia 8 1994 115 120
18. Hill CS Treisman R Transcriptional regulation by extracellular signals: mechanisms and specificity Cell 80 1995 199 211
19. Ihle JN Kerr IM Jaks and Stats in signaling by the cytokine receptor superfamily Trends in Genetics 11 1995 69 74
20. Ilaria RL Jr van Etten RA The SH2 domain of P210BCR/ABL is not required for the transformation of hematopoietic factor-dependent cells Blood 86 1995 3897 3904
21. Ilaria RL Jr van Etten RA P210 and P190 (BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members Journal of Biological Chemistry 271 1996 31704 31710
22. Jain SK Susa M Keeler MK PI-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl Blood 88 1996 1542 1550
23. Janssen JW Ridge SA Papadopoulos P The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event British Journal of Haematology 90 1995 222 224
24. Kabarowski JH Allen PB Wiedemann LM A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells EMBO Journal 13 1994 5887 5895
25. Mandanas RA Leibowitz DS Gharenbaghi K Role of p21 Ras in p210 bcr-abl transformation of murine myeloid cells Blood 82 1993 1838 1847
26. Marshall CJ Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation Cell 80 1995 179 185
27. Marshall CJ Ras effectors Current Opinion in Cell Biology 8 1996 197 204
28. Marshall MS Ras target proteins in eukaryotic cells FASEB Journal 9 1995 1311 1318
29. Mayer BJ Baltimore D Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase Molecular and Cell Biology 14 1994 2883 2894
30. McWhirter JR Galasso DL Wang JY A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins Molecular and Cell Biology 13 1993 7587 7595
31. Medema RH Bos JL The role of p21ras in receptor tyrosine kinase signaling Critical Reviews in Oncogenesis 4 1993 615 661
32. Nichols GL Raines MA Vera JC Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells Blood 84 1994 2912 2918
33. Okuda K Matulonis U Salgia R Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1 Experimental Hematology 22 1994 1111 1117
34. Papadopoulos P Ridge SA Boucher CA The novel activation of ABL by fusion to an etsrelated gene, TEL Cancer Research 55 1995 34 38
35. Pendergast AM Gishizky ML Havlik MH Witte ON SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor-independence Molecular and Cell Biology 13 1993 1728 1736
36. Pendergast AM Quilliam LA Cripe LD BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein Cell 75 1993 175 185
37. Raitano AB Halpern JR Hambuch TM Sawyers CL The Bcr-Abl leukemia oncogene activates Jun Kinase and requires Jun for transformation Proceedings of the National Academy of Sciences of the USA 92 1995 11 746 11 750
38. Saez E Oppenheim H Smoluk J c-fos is not essential for v-abl-induced lymphomagenesis Cancer Research 55 1995 6196 6199
39. Salgia R Uemura N Okuda K CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells Journal of Biological Chemistry 270 1995 29 145 29 150
40. Sanchez I Hughes RT Mayer BJ Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun Nature 372 1994 794 798
41. Sattler M Salgia R Okuda K The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3′ kinase pathway Oncogene 12 1996 839 846
42. Sawyers CL Callahan W Witte ON Dominant negative myc blocks transformation by ABL oncogenes Cell 70 1992 901 910
43. Sawyers CL Gishizky ML Quan S Propagation of human blastic myeloid leukemias in the SCID mouse Blood 79 1992 2089 2098
44. Sawyers CL McLaughlin J Witte ON Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene Journal of Experimental Medicine 181 1995 307 313
45. Schindler C Darnell JE Jr Transcriptional responses to polypeptide ligands: the JAK-STAT pathway Annual Review of Biochemistry 64 1995 621 651
46. Schlessinger J SH2/SH3 signaling proteins Current Opinion in Genetics and Development 4 1994 25 30
47. Seger R Krebs EG The MAPK signaling cascade FASEB Journal 9 1995 726 735
48. Senechal K Halpern J Sawyers CL The CRKL adaptor protein transforms fibroblasts and functions in transformation by the Bcr-Abl oncogene Journal of Biological Chemistry 271 1996 23 255 23 261
49. Shuai K Halpern J ten Hoeve J Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia Oncogene 13 1996 247 254
50. Sirard C Lapidot T Vormoor J Normal leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis Blood 87 1996 1539 1548
51. Skorski T Kanakaraj P Ku DH Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth Journal of Experimental Medicine 179 1994 11 855 11 865
52. Skorski T Kanakaraj P Nieborowska-Skorska M Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells Blood 86 1995 726 736
53. Skorski T Nieborowska-Skorska M Szczylik C C-RAF-1 serine/theonine kinase is required in BCR/ABL-dependent and normal hematopoiesis Cancer Research 55 1995 2275 2278
54. Stewart MJ Litz-Jackson S Burgess GS Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells Leukemia 9 1995 1499 1507
55. Taniguchi T Cytokine signaling through nonreceptor protein tyrosine kinases Science 268 1995 251 255
56. Varticovski L Daley GQ Jackson P Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants Molecular and Cell Biology 11 1991 1107 1113
57. Wang HG Rapp UR Reed JC Bcl-2 targets the protein kinase Raf-1 to mitochondria Cell 87 1996 629 638
58. Warren MK Rose WL Beall LD Cone J CD34+ cell expansion and expression of lineage markers during liquid culture of human progenitor cells Stem Cells 13 1995 167 174
59. Waskiewicz AJ Cooper JA Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast Current Opinion in Cell Biology 7 1995 798 805
60. Yamanashi Y Baltimore D Indentification of the Abl-1 and ras GAP-association 62 kDA protein as a docking protein, Dok Cell 88 1997 205 211
61. Zha J Harada H Yang E Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14–3–3 not BCL-X(L) Cell 87 1996 619 628